SpiderRock Advisors’s Idexx Laboratories IDXX Stock Holding History

SpiderRock Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$758K	Sell	1,500 -700	-32%	-$340K	0.01%	526
2024 Q2	$1.07M	Buy	2,200 +600	+38%	+$301K	0.02%	397
2024 Q1	$848K	Buy	+1,600	New	+$874K	0.02%	422
2023 Q4	–	Hold	0	–	–	–	109
2023 Q3	–	Hold	0	–	–	–	43
2023 Q2	–	Hold	0	–	–	–	44
2023 Q1	–	Hold	0	–	–	–	42
2022 Q4	–	Hold	0	–	–	–	44
2022 Q3	–	Hold	0	–	–	–	38
2022 Q2	–	Hold	0	–	–	–	26
2022 Q1	–	Hold	0	–	–	–	29
2021 Q4	–	Hold	0	–	–	–	21
2021 Q3	–	Hold	0	–	–	–	21
2021 Q2	–	Hold	0	–	–	–	21
2021 Q1	–	Hold	0	–	–	–	21
2020 Q4	–	Hold	0	–	–	–	53
2020 Q3	–	Hold	0	–	–	–	74
2017 Q4	–	Hold	0	–	-$56K	–	212
2017 Q3	–	Hold	0	–	–	–	197

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SpiderRock Advisors's IDXX Position: Q3 2024 in Review

SpiderRock Advisors reduced its Idexx Laboratories (IDXX) stake by 8.5% in Q3 2024, selling an estimated $399K and leaving 8,862 shares worth $4.48M. The position accounts for 0.07% of the portfolio, ranked #184.

SpiderRock Advisors first reported a position in IDXX in Q1 2024 and has held it in 3 quarters since. The position peaked at $4.72M in Q2 2024. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

SpiderRock Advisors held 8,862 shares of Idexx Laboratories worth $4.48M as of Q3 2024.
SpiderRock Advisors sold 821 Idexx Laboratories shares in Q3 2024, an estimated $399K.
Idexx Laboratories made up 0.07% of SpiderRock Advisors's portfolio in Q3 2024, its #184 holding.
SpiderRock Advisors first reported a position in Idexx Laboratories in Q1 2024 and has held it in 3 quarters since.
SpiderRock Advisors's Idexx Laboratories position peaked at $4.72M in Q2 2024.
1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.